Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

VIPR2 antibody (Extracellular)

This anti-VIPR2 antibody is a Rabbit Polyclonal antibody detecting VIPR2 in WB, IF, FACS, IC and LCI. Suitable for Human.
Catalog No. ABIN7043877

Quick Overview for VIPR2 antibody (Extracellular) (ABIN7043877)

Target

See all VIPR2 Antibodies
VIPR2 (Vasoactive Intestinal Peptide Receptor 2 (VIPR2))

Reactivity

  • 34
  • 9
  • 6
  • 2
  • 1
Human

Host

  • 30
  • 6
Rabbit

Clonality

  • 30
  • 5
Polyclonal

Conjugate

  • 27
  • 3
  • 2
  • 2
  • 1
  • 1
This VIPR2 antibody is un-conjugated

Application

  • 27
  • 25
  • 6
  • 5
  • 3
  • 1
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunochromatography (IC), Live Cell Imaging (LCI)
  • Binding Specificity

    • 10
    • 6
    • 5
    • 5
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 25-37, Extracellular

    Purpose

    A Rabbit Polyclonal Antibody to VPAC2 Receptor

    Specificity

    Extracellular, N-terminus

    Cross-Reactivity

    Human, Mouse, Rat

    Predicted Reactivity

    Mouse,rat - identical

    Characteristics

    Anti-VPAC2 (VIPR2) (extracellular) Antibody is directed against an extracellular epitope of human VIP and PACAP receptor 2. Anti-VPAC2 (VIPR2) (extracellular) Antibody (ABIN7043877, ABIN7045331 and ABIN7045332) can be used in western blot analysis, immunocytochemistry and indirect flow cytometry applications. It has been designed to recognize VPAC2 from human, rat and mouse samples.

    Purification

    Affinity purified on immobilized antigen.

    Immunogen

    Immunogen: Synthetic peptide

    Immunogen Sequence: CRFHLEIQEEETK, corresponding to amino acid residues 25-37 of human VPAC2

    Isotype

    IgG
  • Application Notes

    Antigen preadsorption control: 1 μg peptide per 1 μg antibody

    Application Dilutions Immunohistochemistry paraffin embedded sections ihc: N/A

    Application Dilutions Western blot wb: 1:600

    Comment

    Cited Application: IFC

    Negative Control: (ABIN7237559)

    Blocking Peptide: (ABIN7237559)

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Recosntitute with double distilled water (DDW) to a concentration of 1.0 mg/mL.

    Concentration

    1 mg/mL

    Buffer

    PBS pH 7.4

    Storage

    4 °C,-20 °C

    Storage Comment

    Storage before reconstitution: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.

    Storage after reconstitution: The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).

  • Target

    VIPR2 (Vasoactive Intestinal Peptide Receptor 2 (VIPR2))

    Alternative Name

    VIPR2

    Background

    VIP and PACAP receptor 2, Vasoactive intestinal polypeptide receptor 2, Helodermin-preferring VIP receptor, Pituitary adenylate cyclase-activating polypeptide type III receptor, PACAP type III receptor, PACAP-R3,Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP) are prominent neuropeptides that are structurally related. Two receptors have similarly high affinity for VIP and PACAP and have therefore been termed VIP and PACAP receptor 1 (VPAC1) and VIP and PACAP receptor 2 (VPAC2). VPAC2 (also known as vasoactive intestinal peptide receptor 2) belongs to the Class II family of G-protein coupled receptors1. A distinct feature of class II GPCRs is the presence of large N-terminal extracellular domains which contain 10 highly conserved amino acids including six cysteines, putative N terminal leader sequences and several potential N-glycosylation sites1.VPAC2 receptor is expressed in the uterus, prostate, smooth muscle of the gastrointestinal tract, seminal vesicles and skin, blood vessels and thymus2. VPAC2 is also expressed in various brain regions including the thalamus and the suprachiasmatic nuclei (SCN)3.VPAC2 plays important roles in the control of mammalian circadian rhythms in the SCN. Mice lacking VPAC2 show altered circadian rhythms in locomotor behavior, neuronal firing and clock gene expression4. Recent studies have also shown that duplication of the VPAC2 gene, and the resulting higher than normal VPAC2 signaling in patients confers a significant risk to schizophrenia5.

    Alternative names: VPAC2 (VIPR2), VIP and PACAP receptor 2, Vasoactive intestinal polypeptide receptor 2, Helodermin-preferring VIP receptor, Pituitary adenylate cyclase-activating polypeptide type III receptor, PACAP type III receptor, PACAP-R3

    Gene ID

    7434

    NCBI Accession

    NM_003382

    UniProt

    P41587

    Pathways

    cAMP Metabolic Process
You are here:
Chat with us!